Mereo BioPharma Group plc(NASDAQ:MREO) 
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and IT...
Website: http://www.mereobiopharma.com/
Founded: 2015
Full Time Employees: 50
CEO: Denise Scots-Knight
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.14
H 2.17
L 1.93
C 1.99
V 1,691,734
10EMA 1.99
20EMA 1.99
60EMA 1.99
120EMA 1.99
250EMA 1.99